The event saw scientists from each of the major research networks in Dementias Platform UK (DPUK) – Imaging, Stem Cells and Informatics – come together with many of the lead researchers of large clinical studies into dementia. The Deep and Frequent Phenotyping study which is about to launch, is an example of one such study, which aims to pinpoint the signs of dementia much earlier in the disease development.
Dementia affects over 50 million people worldwide and is the biggest public health crisis facing us in the 21st century. We have stepped up the fights against it with this multi-million pound investment. Whilst the money is crucial, what is also important with a programme of this kind is that what it can achieve is greater than the sum of its parts.
- Professor John Gallacher, Director of Dementias Platform UK.
Read more here.